CLINICAL TRIALS PROFILE FOR GOCOVRI
✉ Email this page to a colleague
All Clinical Trials for gocovri
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT04273737 ↗ | Amantadine in Treating Cognitive & Motor Impairments in Adolescents and Adults With Cerebral Palsy | Recruiting | Columbia University | Phase 4 | 2020-02-28 | Cerebral palsy (CP) is a common childhood-onset disability associated with motor and cognitive impairments, however most research is focused on motor outcomes. The aim of this study is to determine the effects of Amantadine, a dopaminergic agonist, on cognitive function in adolescents and adults with CP. |
NCT04387773 ↗ | Effect of GOCOVRI (Amantadine, Extended Release Capsules) on Gait in Parkinson's Disease | Recruiting | Adamas Pharmaceuticals, Inc. | Phase 4 | 2020-11-05 | The purpose of the study is to learn about the effect of GOCOVRI (Amantadine extended release) on activity levels and measures of gait and balance quality in people with Parkinson's disease (PD) and levodopa induced dyskinesia (LID) during daily activities using body-worn sensors. |
NCT04387773 ↗ | Effect of GOCOVRI (Amantadine, Extended Release Capsules) on Gait in Parkinson's Disease | Recruiting | Oregon Health and Science University | Phase 4 | 2020-11-05 | The purpose of the study is to learn about the effect of GOCOVRI (Amantadine extended release) on activity levels and measures of gait and balance quality in people with Parkinson's disease (PD) and levodopa induced dyskinesia (LID) during daily activities using body-worn sensors. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for gocovri
Condition Name
Clinical Trial Locations for gocovri
Trials by Country
Clinical Trial Progress for gocovri
Clinical Trial Phase
Clinical Trial Sponsors for gocovri
Sponsor Name